Research Funding

Global Health

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
Human Heredity and Health in Africa (H3Africa): Ethical, Legal, and Societal Issues (ELSI) Research Program (U01) 9/19/17 RFA-RM-17-021 Ebony Madden
ebony.madden@nih.gov
301-503-5620
Letter of Intent:
30 days prior to the application 
due date
Receipt Date:
12/6/2017
Human Heredity and Health in Africa (H3Africa): Ethical, Legal, and Societal Issues (ELSI) Collaborative Centers (U54) 9/19/17 RFA-RM-17-020 Ebony Madden
ebony.madden@nih.gov
301-503-5620
Letter of Intent:
30 days prior to the application 
due date
Receipt Date:
12/06/2017

 

Glycoscience

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date

Innovative Adaptations to Simplify Existing Technologies for Manipulation and Analysis of Glycans (U01)

8/4/17 RFA-RM-17-029 Karl E. Krueger
kruegerk@mail.nih.gov
240 276-7026
Letter of intent:
30 days prior to the application due date
Receipt Date:
10/27/2017
Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions (U01) 8/4/17 RFA-RM-17-030 Karl E. Krueger
kruegerk@mail.nih.gov
240 276-7026
Letter of intent:
30 days prior to the application due date
Receipt Date:
10/27/2017

 

High-Risk Research: NIH Director's Early Independence Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp) 5/25/16 PA-16-289 Ravi Basavappa
earlyindependence@mail.nih.gov
301 435-7204
 
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp) 5/25/16 PA-16-288 Ravi Basavappa
earlyindependence@mail.nih.gov
301 435-7204
 
 

High-Risk Research: NIH Director's New Innovator Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp) 5/25/16 PA-16-289 Ravi Basavappa
NewInnovatorAward@mail.nih.gov
301 435-7204
 
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp) 5/25/16 PA-16-288 Ravi Basavappa
NewInnovatorAward@mail.nih.gov
301 435-7204
 

 

High-Risk Research: NIH Director's Pioneer Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp) 5/25/16 PA-16-289 Ravi Basavappa
PioneerAwards@mail.nih.gov
301 435-7204
 
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp) 5/25/16 PA-16-288 Ravi Basavappa
PioneerAwards@mail.nih.gov
301 435-7204
 

 

Metabolomics

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date

National Metabolomics Data Repository (NMDR) (U2C)

8/1/2017 RFA-RM-17-011 Arthur L. Castle
castlea@mail.nih.gov  
301-594-7719
Letter of Intent:
9/12/2017
Receipt Date:
10/20/2017

Metabolomic Data Analysis and Interpretation Tools (U01)

8/1/2017 RFA-RM-17-012 Krista A. Zanetti
zanettik@mail.nih.gov
240-276-6843
Letter of Intent:
9/12/2017
Receipt Date:
10/20/2017

Compound Identification Development Cores (U2C)

8/1/2017 RFA-RM-17-013 David Balshaw
balshaw@niehs.nih.gov
919-541 2448
Letter of Intent:
9/12/2017
Receipt Date:
10/20/2017

Stakeholder Engagement and Program Coordination Center (SEPCC) (U2C)

8/1/2017 RFA-RM-17-014 Arthur L. Castle
castlea@mail.nih.gov  
301-594-7719
Letter of Intent:
9/12/2017
Receipt Date:
10/20/2017

 

Science of Behavior Change

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
Notice Announcing Applicant Information Webinars for Science of Behavior Change Common Fund Program Funding Opportunity Announcements (RFA-RM-17-022, RFA-RM-17-023, RFA-RM-17-024, RFA-RM-17-028) 10/2/17 NOT-RM-17-039 Will M. Aklin
will.aklin@nih.gov
301-827-5909
Paige Green
paige.green@nih.gov
240-276-6899
Applicant Information Webinars scheduled for 
Thursday, 10/26/2017 
from 1-2:30 pm Eastern time
Monday, 10/30/2017 
from 12-1:30 pm Eastern time
Science of Behavior Change: Revision Applications for Use-inspired Research to Optimize Adherence, Behavior Change Interventions, and Outcomes (R01) 9/18/17 RFA-RM-17-022 Will M. Aklin
will.aklin@nih.gov
301-827-5909
Paige Green
paige.green@nih.gov
240-276-6899
Jonathan W. King
jonathan.king@nih.gov
301-594-5942
Melissa W. Riddle
melissa.riddle@nih.gov
301-451-3888
Letter of Intent:
11/5/2017
Receipt Date:
12/5/2017
Science of Behavior Change: Revision Applications for Use-inspired Research to Optimize Adherence, Behavior Change Interventions, and Outcomes (U01) 9/18/17 RFA-RM-17-023 Will M. Aklin
will.aklin@nih.gov
301-827-5909
Paige Green
paige.green@nih.gov
240-276-6899
Jonathan W. King
jonathan.king@nih.gov
301-594-5942
Melissa W. Riddle
melissa.riddle@nih.gov
301-451-3888
Letter of Intent:
11/5/2017
Receipt Date:
12/5/2017
Science of Behavior Change: Revision Applications for Use-inspired Research to Optimize Adherence, Behavior Change Interventions, and Outcomes (R34) 9/18/17 RFA-RM-17-024 Will M. Aklin
will.aklin@nih.gov
301-827-5909
Paige Green
paige.green@nih.gov
240-276-6899
Jonathan W. King
jonathan.king@nih.gov
301-594-5942
Melissa W. Riddle
melissa.riddle@nih.gov
301-451-3888
Letter of Intent:
11/5/2017
Receipt Date:
12/5/2017
Science of Behavior Change: Use-inspired Research to Optimize Adherence, Behavior Change Interventions, and Outcomes (R21) 9/18/17 RFA-RM-17-028 Will M. Aklin
will.aklin@nih.gov
301-827-5909
Paige Green
paige.green@nih.gov
240-276-6899
Jonathan W. King
jonathan.king@nih.gov
301-594-5942
Melissa W. Riddle
melissa.riddle@nih.gov
301-451-3888
Letter of Intent:
11/5/2017
Receipt Date:
12/5/2017

 

Stimulating Peripheral Activity to Relieve Conditions (SPARC)

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
Request for Information (RFI): Seeking Input from Industry on Enhancing the Data Yield from Clinical Studies of Peripheral Neuromodulation Devices 10/6/2017 NOT-RM-17-015 Siavash Vaziri
SPARC_TPNI@mail.nih.gov
301-594-8921    
Responses by:
12/1/2017
Request for Information (RFI): Seeking Input from Surgeons and Interventionalists on Improving the Clinical Study and Use of New and Established Peripheral Neuromodulation Devices 10/6/2017 NOT-RM-17-023 Siavash Vaziri
SPARC_TPNI@mail.nih.gov
301-594-8921    
Responses by:
12/1/2017

Limited Competition - Stimulating Peripheral Activity to Relieve Conditions (SPARC): Technologies to Understand the Control of Organ Function by the Peripheral Nervous System (OT2)

4/11/17 RFA-RM-17-010 Michael B. Wolfson 
SPARC_NextGen-Tools@mail.nih.gov 
See RM-17-009
Limited Competition - Stimulating Peripheral Activity to Relieve Conditions (SPARC): Comprehensive Functional Mapping of Neuroanatomy and Neurobiology of Organs (OT2) 11/17/2015 RFA-RM-15-018 Jill L. Carrington
carringj@mail.nih.gov
301 402-0671
See RFA-RM-15-003
Pre-application: Stimulating Peripheral Activity to Relieve Conditions (SPARC): Technologies to Understand the Control of Organ Function by the Peripheral Nervous System (OT1) 3/17/17 RFA-RM-17-009 Michael B. Wolfson 
Andrew C. Weitz 
SPARC_NextGen-Tools@mail.nih.gov
Receipt Date:
5/1/2017
8/1/2017
11/1/2017
2/1/2018
5/1/2018
8/1/2018
11/1/2018

 

Undiagnosed Diseases Network

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date

Metabolomics Core for the Undiagnosed Diseases Network (UDN) Phase II (U01)

8/15/17 RFA-RM-17-015 Tiina Urv
urvtiin@mail.nih.gov
301-827-2746
Letter of Intent:
10/2/2017
Receipt Date:
11/2/2017
Sequencing Core(s) for the Undiagnosed Diseases Network (UDN) Phase II (U01) 8/15/17     RFA-RM-17-016     Jyoti Dayal
jyotig@mail.nih.gov
301-480-2307
Letter of Intent:
10/2/2017
Receipt Date:
11/2/2017

Model Organisms Screening Center for the Undiagnosed Diseases Network (UDN) Phase II (U54)

8/15/17 RFA-RM-17-017 Laura Mamounas
mamounas@ninds.nih.gov
301-496-5745
Letter of Intent:
10/2/2017
Receipt Date:
11/2/2017
Coordinating Center for the Undiagnosed Diseases Network (UDN) Phase II (U01) 8/15/17 RFA-RM-17-018 Anastasia L. Wise
anastasia.wise@nih.gov
301- 480-3517
Letter of Intent:
10/2/2017
Receipt Date:
11/2/2017
Clinical Sites for the Undiagnosed Diseases Network (UDN) Phase II (U01) 8/15/17 RFA-RM-17-019 Anastasia L. Wise
anastasia.wise@nih.gov
301- 480-3517
Letter of Intent:
10/2/2017
Receipt Date:
11/2/2017
 

 

Past Funding Opportunities

This page last reviewed on October 17, 2017